Annual Results Results Snapshot
Figures in Rs cr
Standalone Annual Results
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Mar'17
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2023 is -43.09% vs -8.13% in Mar 2022
Standalone Net Profit
YoY Growth in year ended Mar 2023 is -94.97% vs 33.10% in Mar 2022
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2023 is -269.94% vs 77.38% in Mar 2022
Interest
YoY Growth in year ended Mar 2023 is 25.94% vs 17.19% in Mar 2022
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2023 has fallen from Mar 2022
Compare Annual Results Of Bharat Immunolog With
Figures in Rs cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
44.61
8,558.51
-8,513.90
-99.48%
Other Operating Income
0.00
0.00
0.00
Total Operating income
44.61
8,558.51
-8,513.90
-99.48%
Raw Material Cost
33.04
859.11
-826.07
-96.15%
Purchase of Finished goods
0.00
1,825.86
-1,825.86
-100.00%
(Increase) / Decrease In Stocks
5.95
-60.74
66.69
109.80%
Employee Cost
15.32
1,890.84
-1,875.52
-99.19%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
8.76
1,859.00
-1,850.24
-99.53%
Total Expenditure (Excl Depreciation)
63.07
6,374.07
-6,311.00
-99.01%
Operating Profit (PBDIT) excl Other Income
-18.46
2,184.44
-2,202.90
-100.85%
Other Income
2.80
266.64
-263.84
-98.95%
Operating Profit (PBDIT)
-15.66
2,451.08
-2,466.74
-100.64%
Interest
7.04
14.57
-7.53
-51.68%
Exceptional Items
0.00
103.53
-103.53
-100.00%
Gross Profit (PBDT)
-22.70
2,436.51
-2,459.21
-100.93%
Depreciation
0.15
317.46
-317.31
-99.95%
Profit Before Tax
-22.85
2,119.05
-2,141.90
-101.08%
Tax
-5.79
399.17
-404.96
-101.45%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-17.06
1,719.88
-1,736.94
-100.99%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
103.53
-103.53
-100.00%
Net Profit
-17.06
1,823.41
-1,840.47
-100.94%
Equity Capital
43.18
40.06
3.12
7.79%
Face Value
10.00
1.00
0.00
Reserves
44.62
9,583.75
-9,539.13
-99.53%
Earnings per share (EPS)
-3.95
45.52
-49.47
-108.68%
Diluted Earnings per share
-3.95
45.45
-49.40
-108.69%
Operating Profit Margin (Excl OI)
-41.38%
25.52%
0.00
-66.90%
Gross Profit Margin
-50.89%
28.47%
0.00
-79.36%
PAT Margin
-38.24%
20.10%
0.00
-58.34%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 44.61 Cr
in Mar 2023Figures in Rs Cr
YoY Growth in year ended Mar 2023 is -43.09% vs -8.13% in Mar 2022
Annual - Standalone Net Profit
Standalone Net Profit -17.06 Cr
in Mar 2023Figures in Rs Cr
YoY Growth in year ended Mar 2023 is -94.97% vs 33.10% in Mar 2022
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -18.46 Cr
in Mar 2023Figures in Rs Cr
YoY Growth in year ended Mar 2023 is -269.94% vs 77.38% in Mar 2022
Annual - Interest
Interest 7.04 Cr
in Mar 2023Figures in Rs Cr
YoY Growth in year ended Mar 2023 is 25.94% vs 17.19% in Mar 2022
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -41.38%
in Mar 2023Figures in Rs %
YoY Growth in year ended Mar 2023 has fallen from Mar 2022
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
